TH-287

CAS No. 1609960-30-6

TH-287 ( TH287 )

Catalog No. M12321 CAS No. 1609960-30-6

A potent and selective inhibitor of MTH1 protein with IC50 of 0.8 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 37 In Stock
5MG 59 In Stock
10MG 87 In Stock
25MG 178 In Stock
50MG 347 In Stock
100MG 516 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TH-287
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and selective inhibitor of MTH1 protein with IC50 of 0.8 nM.
  • Description
    A potent and selective inhibitor of MTH1 protein with IC50 of 0.8 nM; shows no relevant inhibition for MTH2,NUDT5, NUDT12,NUDT14,NUDT16 and other proteinswith known nucleoside triphosphate pyrophosphatase activity; causees incorporation of oxidized dNTPs in cancer cells, leading to DNA damage, cytotoxicity and therapeutic responses in patient-derived mouse xenografts.
  • Synonyms
    TH287
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    MTH1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1609960-30-6
  • Formula Weight
    269.13
  • Molecular Formula
    C11H10Cl2N4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 2.6 mg/mL
  • SMILES
    NC1=NC(C2=CC=CC(Cl)=C2Cl)=CC(NC)=N1
  • Chemical Name
    2,4-Pyrimidinediamine, 6-(2,3-dichlorophenyl)-N4-methyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gad H, et al. Nature. 2014 Apr 10;508(7495):215-21.
2. Wang M, et al. Sci Rep. 2017 Jan 11;7:40557.
3. Kawamura T, et al. Sci Rep. 2016 May 23;6:26521.
molnova catalog
related products
  • L82-G17

    L82-G17 is an uncompetitive LigI-selective inhibitor in human cells with utility as a probe of the catalytic activity and cellular functions of LigI.

  • JH-RE-06

    JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing the recruitment of mutagenic POLζ. JH-RE-06 is an effective REV1-REV7 interface inhibitor (IC50=0.78 μM; Kd=0.42 μM), which targets REV1 that interacts with the REV7 subunit of POLζ. JH-RE-06 also improves chemotherapy.

  • NITD-2

    NITD-2 is a dengue virus (DENV) polymerase inhibitor, inhibits the DENV RdRp-mediated RNA elongation.?